Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Ebola-C Inc
WARNING LETTER
•Ebola-C Inc•October 31, 2014

Ebola-C Inc – FDA Warning Letter, Oct 31, 2014

Record Details

In October 2014, the FDA and FTC reviewed the website http://www.ebola-c.com, which sells "Ebola-C." The product is promoted with therapeutic claims, such as "DEFEND YOURSELF NOW!!!!! EBOLA-C" and "Specifically formulated for Ebola-C," establishing it as a drug under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act).

The FDA determined "Ebola-C" is an unapproved "new drug" under section 201(p) of the Act because it is not generally recognized as safe and effective for its claimed uses. Introducing or delivering this product into interstate commerce without prior FDA approval violates sections 505(a) and 301(d) of the Act.

Furthermore, the product is misbranded under section 502(f)(1) of the Act because it is intended for a condition not amenable to self-diagnosis and treatment, meaning adequate directions for layperson use cannot be provided. Introducing a misbranded drug into interstate commerce violates section 301(a) of the Act.

The FDA requires immediate action to cease distributing unapproved Ebola Virus-related products. The firm must respond within 15 working days via email to EbolaTaskForce-CFSAN@fda.hhs.gov, detailing corrective actions. Failure to comply may result in enforcement

Company
Ebola-C Inc
Inspection date
October 31, 2014
Product type
Food
Office
Center for Food Safety and Applied Nutrition
People
  • Mary K. Engle (Associate Director)
  • William A. Correll (Director)
View Company Profile

ID · 927c0b8b-164e-4ed2-a041-73189e23e144

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 33121 U.S.C. 35221 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ebola-C Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.